Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cubist Pharmaceuticals Inc    CBST   US2296781071

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Cubist Pharmaceuticals Inc : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales6367549261 0251 1301 268
Operating income (EBITDA)202166309189261338
Operating profit (EBIT)190153276156250379
Pre-Tax Profit (EBT)--200---
Net income94,333,015480,8137223
EPS ( $)1,550,522,101,191,762,60
Dividend per Share ( $)------
Yield------
Announcement Date01/20/2011
09:01pm		01/19/2012
09:00pm		01/23/2013
09:00pm		---
Finances - Leverage
Cubist Pharmaceuticals Inc : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt--2641528,72-
Finance-----207
Operating income (EBITDA)202166309189261338
Leverage
(Debt/EBITDA)		--0,85x0,81x0,03x-
Capital Expenditure17,5-18,130,228,630,5
Book Value Per Share (BVPS)--15,3 $15,3 $16,5 $18,5 $
Cash Flow per Share-3,18 $2,65 $2,10 $2,79 $4,68 $
Announcement Date01/20/2011
09:01pm		01/19/2012
09:00pm		01/23/2013
09:00pm		---
Balance Sheet Analysis
Cubist Pharmaceuticals Inc : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 3 659 M$ -
Company Value 3 811 M$ 3 667 M$
Valuation 2013e 2014e
PER (Price / EPS) 47,0x 32,0x
Capitalization / Revenue 3,57x 3,24x
EV / Revenue 3,72x 3,24x
EV / EBITDA 20,2x 14,1x
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 15,3% 22,1%
operating laverage (Delta EBIT / Delta Sales) - 5,86x
Net Margin (Net Profit / Revenue) 7,88% 12,1%
ROA (Net Profit / Asset) 4,30% 5,60%
ROE (Net Profit / Equities) 15,6% 13,5%
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   2,94% 2,53%
Cash Flow / Sales (Taux d'autofinancement) 13,3% 16,0%
Capital Intensity (Assets / Sales) 1,83x 2,16x
Financial Leverage (Net Debt / EBITDA) 0,81x 0,03x
Price Earning Ratio
Cubist Pharmaceuticals Inc : Price Earning Ratio
EPS & Dividend
Cubist Pharmaceuticals Inc : EPS Dividend
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.